Table 1.
Sample Demographic and Descriptive Characteristics – Comparison Study
Data relative to subject cohort used for comparison studies. Brain weight expressed in grams. Abbreviations: CPZ, chlorpromazine-equivalent (CPZ) dose (expressed in average mg/day during the last month of life); Dx, diagnosis; PMI, postmortem interval (hours).
| Dx | Age | Sex | PMI | Brain weight | CPZ last month of life |
Age at onset |
Years of illness |
|---|---|---|---|---|---|---|---|
| SZ | 83 | M | 7 | 1200 | 0 | 21 | 62 |
| SZ | 74 | F | 15 | 1140 | 600 | 18 | 56 |
| SZ | 79 | F | 8 | 1040 | 0 | NK | NK |
| SZ | 75 | F | 16 | 1219 | 900 | 23 | 52 |
| SZ | 76 | M | 10 | 1322 | 600 | 20 | 56 |
| SZ | 70 | M | 17 | 1200 | 850 | 32 | 38 |
| SZ | 72 | F | 10 | 1157 | NK | 24 | 48 |
| SZ | 71 | M | 10 | 1188 | 0 | 34 | 37 |
| SZ | 74 | M | 14 | 1260 | 100 | 23 | 51 |
| SZ | 80 | F | 11 | 1060 | 100 | 22 | 58 |
| 10 |
75.4 +/−
4.2 |
5 M/
5 F |
11.8
+/−3.5 |
1178.6
+/−382.4 |
350
+/−382.4 |
24.11
+/−5.4 |
50.89
+/−8.6 |
| C | 43 | M | 30.5 | 1545 | NA | NA | NA |
| C | 73 | M | 8 | 1249 | NA | NA | NA |
| C | 74 | F | 3.5 | 1000 | NA | NA | NA |
| C | 91 | F | 11.5 | 1140 | NA | NA | NA |
| C | 74 | F | 6 | 1250 | NA | NA | NA |
| C | 69 | M | 11 | 1625 | NA | NA | NA |
| C | 63 | M | 5 | 1360 | NA | NA | NA |
| C | 67 | F | 5.5 | 1100 | NA | NA | NA |
| C | 98 | M | 15 | 1340 | NA | NA | NA |
| C | 43 | M | 30.5 | 1545 | NA | NA | NA |
| 9 |
69.5
+/− 17.6 |
5 M/
5 F |
12.7
+/−10 |
1315.4
+/−207.9 |
NA | NA | NA |